SCHEMBL12201063

SCHEMBL12201063

NC1C(=O)C=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11508917 0.74 HSP90AA1 (0.35)
Bromide SCHEMBL11510071 0.74 HSP90AA1 (0.35)
SCHEMBL4245299 0.73 HSP90AA1 (0.35)
SCHEMBL18917295 0.65 KDM4E (0.48)
SCHEMBL28922481 0.64
SCHEMBL12235919 0.62
SCHEMBL12706333 0.61
SCHEMBL17131854 0.61 ALDH1A1 (0.31)
SCHEMBL10046205 0.61
SCHEMBL12159902 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150159153-A1 METHOD FOR TRANSFECTION OF NUCLEIC ACIDS INTO EUKARYOTIC CELLS IN 3D SCAFFOLD COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-06-11 US disclosed
US-8034959-B2 Methods of treating cancer with an antibody-drug conjugate MEDAREX, INC. (US) 2011-10-11 US disclosed
US-7977465-B2 Peptidyl prodrugs and linkers and stabilizers useful therefor MEDAREX, INC. (US) 2011-07-12 US disclosed
US-20090209734-A1 PEPTIDYL PRODRUGS AND LINKERS AND STABILIZERS USEFUL THEREFOR MEDAREX, INC. (US) 2009-08-20 US disclosed
US-20090175888-A1 METHODS OF TREATING CANCER WITH AN ANTIBODY-DRUG CONJUGATE MEDAREX, INC. (US) 2009-07-09 US disclosed